SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-022393
Filing Date
2012-03-29
Accepted
2012-03-29 16:09:07
Documents
4
Period of Report
2012-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-8369_18k.htm 8-K 27963
2 EX-99.1 a12-8369_1ex99d1.htm EX-99.1 195044
3 GRAPHIC g83691mmi001.jpg GRAPHIC 3409
4 GRAPHIC g83691mmi002.jpg GRAPHIC 2014
  Complete submission text file 0001104659-12-022393.txt   232026
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 12724051
SIC: 2834 Pharmaceutical Preparations